[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"post-menopausal-osteoporosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:post-menopausal-osteoporosis":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100601028","evaluation-of-adherence-with-bisphosphonates-and-calcium-and-vitamin-d-supplements-in-women-with-postmenopausal-osteoporosis-100601028",false,"NCT07105163","Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis","Observational, Cross-sectional, Multicenter Study to Evaluate Adherence to Different Treatment Regimens With Oral Bisphosphonates and Calcium and Vitamin D Supplements in Postmenopausal Osteoporosis.","OSTEOAD","Inclusion Criteria:\n\n1. \\- Women diagnosed with postmenopausal OP.\n2. \\- Women who had been prescribed oral treatment with a BP administered monthly or weekly together with a Ca\u002FD supplement (sachets or chewable tablets) administered daily, at least 6 months prior to inclusion in the study.\n3. \\- Women who had given their written informed consent before participating in the study.\n\nExclusion Criteria:\n\nNone","FEMALE",{"count":19,"type":20},480,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.",[24],"Post Menopausal Osteoporosis",[26,27,28,29,30,31],"Procare","Post menopausal osteoporosis","Bisphosphonate","calcium","vitamin D","supplement","RECRUITING","2025-07-29",{"date":35,"type":36},"2025-08-05","ACTUAL",{"date":38,"type":36},"2025-03-03",{"date":40,"type":20},"2025-12",{"name":42,"class":43},"Procare Health Iberia S.L.","INDUSTRY",21,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":62,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":78},"100483167","study-of-the-impact-of-mother-of-pearl-nutritional-supplementation-on-the-prevention-of-post-menopausal-osteoporosis-100483167","NCT05571514","Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis","Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis: Multicentre, Double-blind Randomized Versus Positive Comparator Study","NUTRANACRE","Inclusion Criteria:\n\n* Post-menopausal women (50-65y) with risk of becoming osteoporotic\n* T-score between -1 and -3\n* Absence of fragility fractures history\n\nExclusion Criteria:\n\n* absence of parathyroid glands (phospho-calcic regulation)\n* presence of kidney stones\n* patients who follow a treatment that could interfere with bone metabolism (corticotherapy, menopausal hormonal therapy, anti-oestrogen treatment, non-controlled hyperthyroiditis, hyper- and hypothyroiditis)\n* bone diseases (Paget'disease, osteomalacia)\n* chronic alcoholism","50 Years","65 Years",{"count":56,"type":20},200,"INTERVENTIONAL",[59],"NA","Post-menopausal osteoporosis and the resulting fractures are an important cause of disability and loss of independence. They also increase the risk of morbidity and mortality.\n\nGiven potential side effects, hormone replacement therapy is no longer recommended for menopausal women with risk of becoming osteoporotic. The very significant decrease in the use of these treatments is suspected of contributing to a resurgence in the incidence of osteoporotic fractures, particularly in women before the age of 70. There is a need for prevention of osteoporosis.",[24],[63,64,65,66,67],"Mother-of-pearl","Osteoporosis","Ageing","Nutrition Health","Prevention","2025-06-18",{"date":70,"type":36},"2025-06-19",{"date":72,"type":36},"2023-05-12",{"date":74,"type":20},"2028-11",{"name":76,"class":77},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",7]